$CRVS

$10.45 -$0.08 (0.76%) Close

$CRVS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 84.1M shares outstanding

Who owns CRVS?

By type of holder

Institutions 83.8% Insiders 16.2% Everyone else 0.0%

Concentration Top 10 holders own 61.9%

Thompson Peter A 10.5% · Orbimed Capital GP V LLC 10.2%

Institutional ownership

83.8%

+0.5 pts vs last qtr

Institutional holders

172

+8 vs last qtr

Net shares bought

+421.9K

by institutions in Q2 2026

New / sold out

40 / 32

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +978.4K
State Street Corp +908.1K

Biggest sellers in Q2 2026

Commodore Capital LP SOLD OUT −2.3M
MPM Bioimpact LLC SOLD OUT −1.7M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Corvus Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+112.9%

+13.42% a year

Each share's claim on the business

−53.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $30.5M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years46% 3–5 years1% 1–3 years25% Under 1 year28%

Quarterly turnover

13.1%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting CRVS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
OA Orbimed Advisors LLC 13D · 10.3%	7.2M	8.52%	Unchanged	≤2021	2.0%
Shares held by quarter Peak holding7.2M (Q2'25) Change over 8 quarters+221.4K Share of the company8.520% Disclosed stake13D · 10.3% Orbimed Advisors LLC's full portfolio →
B BlackRock, Inc.	7.1M	8.49%	+978.4K (+15.9%)	≤2021	0.0%
Shares held by quarter Peak holding7.1M (Q2'26) Change over 8 quarters+6.5M Share of the company8.490% BlackRock, Inc.'s full portfolio →

Orbimed Advisors LLC

13D · 10.3%

7.2M

% of company

8.52%

Change vs last qtr

Unchanged

Held since

≤2021

BlackRock, Inc.

7.1M

% of company

8.49%

Change vs last qtr

+978.4K (+15.9%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Corvus Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CRVS on Form N-PORT; together they hold 23.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$43.8M	2.9M	3.49%	0.41%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$35.5M	2.4M	2.82%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$43.8M

% of company

3.49%

% of the fund

0.41%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$35.5M

% of company

2.82%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Corvus Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TP Thompson Peter A Insider	8.8M	10.48%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company10.480% Thompson Peter A's insider activity →
OC Orbimed Capital GP V LLC 5%+ holder 13D · 10.3%	8.6M	10.23%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.230% Disclosed stake13D · 10.3% View the 13D/G filing →

Thompson Peter A

Insider

8.8M

% of company

10.48%

Change vs last qtr

—

Held since

—

Orbimed Capital GP V LLC

5%+ holder13D · 10.3%

8.6M

% of company

10.23%

Change vs last qtr

—

Held since

—

13 more holders behind a free account

See every insider and 5%+ holder of Corvus Pharmaceuticals Inc.

Comments